GOFINTECH QUANT(00290)
Search documents
国富量子(00290) - 截至二零二五年十一月三十日股份发行人的证券变动月报表
2025-12-02 08:03
截至月份: 2025年11月30日 狀態: 新提交 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 FF301 致:香港交易及結算所有限公司 公司名稱: 國富量子創新有限公司(於開曼群島註冊成立之有限公司) 呈交日期: 2025年12月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00290 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | HKD | | 0.1 HKD | | 2,000,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 20,000,000,000 | HKD | | 0.1 HKD | | 2,000,000,000 ...
港股公告掘金 | 美团-W第三季度收入约955亿元 同比增长约2% 闪购与全球化布局亮点突出
Zhi Tong Cai Jing· 2025-11-30 13:04
Major Events - Excellence Risen (02687) plans to offer 6.6667 million H-shares globally from November 28 to December 3 [1] - Naxin Micro (02676) plans to offer 19.0684 million shares globally from November 28 to December 3 [1] - Stone Four Pharmaceutical Group (02005) received production registration approval for the sustained-release capsule of Tofacitinib (4mg) [1] - Innovent Biologics (01801) received approval from the National Medical Products Administration for its drug, Xinmeiyue® (Pikankizumab injection), for treating moderate to severe plaque psoriasis [1] - Jiangxi Copper (00358) intends to acquire shares of the overseas-listed company SolGold Plc [1] - ZTO Express-W (02057) plans to acquire 100% equity of Zhejiang Xinglian for 178 million yuan to enhance end-to-end domestic and international air logistics capabilities [1] - China Shenhua (01088) completed 168 hours of trial operation for the Beihai Phase II Unit 3 and transferred it to commercial operation [1] - Zhidatech (02650) signed a major contract worth over 100 million yuan for electric vehicle charging stations with Saudi Controls Ltd, expanding into the Middle East market [1] - Hendry (03389) received a voluntary cash offer from Junya at a 12% premium and will resume trading on December 1 [1] - Zijin Mining (02899) donated 20 million HKD to support post-fire reconstruction in Hong Kong's Tai Po District [1] - Guoquan (02517) donated 10 million HKD for fire rescue efforts in Hong Kong's Tai Po [1] - InnoCare Pharma (02577) donated 2 million HKD to assist in fire rescue efforts in Hong Kong's Tai Po [1] Operating Performance - Meituan-W (03690) reported Q3 revenue of approximately 95.5 billion HKD, a year-on-year increase of about 2%, with highlights in flash purchase and global expansion [1] - China Gas (00384) reported a mid-term profit attributable to shareholders of 1.334 billion HKD, with an interim dividend of 0.15 HKD per share [1] - Zhixing Group Holdings (01539) reported a mid-term profit attributable to shareholders of 27.533 million HKD, a year-on-year increase of 35.68%, with gross margin rising to approximately 67.3% [1] - Guofu Quantum (00290) reported mid-term revenue of 1.027 billion HKD, a year-on-year increase of 4564.52% [1] - Yuhua Education (06169) reported an annual adjusted profit attributable to shareholders of 914 million HKD, a year-on-year increase of 95.6% [1] - China Water Affairs (00855) achieved mid-term revenue of approximately 5.183 billion HKD, with a dividend of 0.13 HKD per share [1] - Zhonghui Group (00382) reported annual revenue of approximately 2.489 billion HKD, a year-on-year increase of 7.7% [1]
国富量子(00290.HK)中期扭亏为盈至2.07亿港元
Ge Long Hui A P P· 2025-11-28 14:56
格隆汇11月28日丨国富量子(00290.HK)公告,截至2025年9月30日止6个月中期业绩,集团收入及按公平 值列入损益账投资公平值收益净额为11.8亿港元,同比增加31.76倍。该增加主要是由于贸易及供应链运 营业务收入以及证券经纪及融资孖展业务收入增加,及集团股权投资业务产生按公平值列入损益账投资 公平值收益净额增加。集团于本期间录得盈利2.07亿港元,而2024年同期录得亏损1090.9万港元。期间 实现扭亏为盈,主要由于与2024年同期相比,(i)收入及按公平值列入损益账投资公平值收益净额增加; 及(ii)录得出售加密货币收益;及(iii)本集团主营业务(其中包括集团证券经纪及孖展融资业务)产生经营 溢利增加。期间每股基本及摊薄盈利分别为2.90港仙及2.88港仙,而2024年同期每股基本及摊薄亏损分 别为0.17港仙及0.17港仙。 ...
国富量子(00290)发布中期业绩,收入10.27亿港元 同比增长4564.52%
智通财经网· 2025-11-28 14:48
Core Viewpoint - Guofu Quantum (00290) reported a significant increase in revenue and profit for the six months ending September 30, 2025, driven by growth in trade and supply chain operations, as well as securities brokerage and financing business [1] Financial Performance - The company achieved a revenue of HKD 1.027 billion, representing a year-on-year increase of 4564.52% [1] - Profit attributable to shareholders was HKD 207 million, with basic earnings per share of HKD 0.029 [1] - The net fair value gains from investments, included in profit or loss, amounted to approximately HKD 1.181 billion, a 31.76-fold increase compared to HKD 37.174 million for the same period in 2024 [1] Business Drivers - The increase in revenue and net fair value gains was primarily due to higher income from trade and supply chain operations, as well as increased revenue from securities brokerage and margin financing [1] - The company also benefited from gains from cryptocurrency sales and increased operating profit from its main business, including securities brokerage and margin financing [1] Future Outlook - The company plans to leverage its traditional financial advantages, focusing on "quantum technology + digital assets" as dual engines for growth, aiming to innovate in financial infrastructure [1]
国富量子发布中期业绩,收入10.27亿港元 同比增长4564.52%
Zhi Tong Cai Jing· 2025-11-28 14:48
Core Insights - Guofu Quantum (00290) reported a revenue of HKD 1.027 billion for the six months ending September 30, 2025, representing a year-on-year increase of 4564.52% [1] - The profit attributable to the company's owners was HKD 207 million, with basic earnings per share of HKD 0.029 [1] - The group's revenue and net fair value gains from investments recognized in profit or loss amounted to approximately HKD 1.181 billion, a 31.76-fold increase compared to HKD 37.174 million for the six months ending September 30, 2024 [1] Revenue Drivers - The significant increase in revenue was primarily driven by growth in trade and supply chain operations, as well as increased income from securities brokerage and margin financing businesses [1] - The group's equity investment business also contributed to the net fair value gains recognized in profit or loss [1] Profitability Factors - The profitability during the period was mainly due to the increase in revenue and net fair value gains compared to the same period in 2024 [1] - Additional profit was generated from the sale of cryptocurrencies and increased operating profit from the group's main businesses, including securities brokerage and margin financing [1] Future Outlook - The company plans to leverage its traditional financial advantages, focusing on "quantum technology + digital assets" as dual core engines [1] - The strategy involves using quantum technology as a foundation to innovate in digital assets, aiming to advance financial infrastructure and promote financial innovation [1]
国富量子(00290) - 2026 - 中期业绩
2025-11-28 14:27
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責, 對其準確性或完整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任 何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 GoFintech Quantum Innovation Limited 國富量子創新有限公司 (前稱 GoFintech Innovation Limited 國富創新有限公司) (於開曼群島註冊成立之有限公司) 網址:https://290.com.hk (股份代號:290) 截至二零二五年九月三十日止六個月之 中期業績公告 國富量子創新有限公司(「本公司」)董事(「董事」)會(「董事會」)謹此公佈本公司 及其附屬公司(統稱「本集團」)截至二零二五年九月三十日止六個月(「本期間」) 之未經審核業績及二零二四年同期之比較數字。本集團之本期間未經審核中期財 務資料已獲董事會審核委員會(「審核委員會」)及本公司外部核數師審閱。 1 簡明綜合損益及其他全面收益表 截至二零二五年九月三十日止六個月 | | | 截至九月三十日止六個月 | | | --- | --- | --- | --- | | | | 二零 ...
国富量子(00290) - 进一步延长有关贷款资本化(涉及根据特别授权发行新股份)之关连交易之最后截...
2025-11-28 12:07
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責, 對其準確性或完整性亦不發表任何聲明,並明確表示,概不會就因本公告全部或 任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 本公告僅供參考,並不構成收購、購買或認購本公司任何證券之邀請或要約。 本公告不得直接或間接於或向美國(包括其領土及屬地、美國任何州及哥倫比亞 特區)派發。本公告並不構成或組成在美國境內購買或認購證券之任何要約或招 攬之一部分。本公告所述資本化股份並無亦不會根據一九三三年美國證券法(「證 券法」)登記。 資本化股份不得在美國境內或向美籍人士(定義見證券法S規例)或以其名義或為 其利益提呈發售或出售,惟根據證券法之登記規定獲豁免者除外。將不會於美國 公開發售證券。 由於需要額外時間達成先決條件,本公司與貸款人經公平磋商後,於二零二五年 十一月二十八日(聯交所交易時段後)訂立貸款資本化協議之第五份補充協議,據 此,訂約方同意將最後截止日期進一步延至二零二五年十二月三十一日(或貸款 資本化協議訂約方可能書面協定之較後日期)。除上述變動外,貸款資本化協議之 所有條款及條件維持不變,並繼續具有十足效力及作用。 ( ...
国富量子(00290) - 进一步延长最后截止日期 - 有关新订根据一般授权认购新股份之第四份补充公...
2025-11-27 09:45
本公告僅供參考,並不構成收購、購買或認購本公司任何證券之邀請或要約。 本公告不會直接或間接於或向美國(包括美國的領土及屬地、任何州以及哥倫比 亞特區)派發。本公告並不構成或組成在美國境內購買或認購證券的任何要約或 招攬的一部分。本公告所述認購股份並無亦不會根據一九三三年美國證券法(「證 券法」)登記。 認購股份不得在美國境內或向美籍人士(定義見證券法S規例)或以其名義或為其 利益提呈發售或出售,惟獲豁免遵守證券法登記規定者除外。證券將不會於美國 公開發售。 GoFintech Quantum Innovation Limited 國富量子創新有限公司 (前稱 GoFintech Innovation Limited 國富創新有限公司) (於開曼群島註冊成立之有限公司) 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責, 對其準確性或完整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任 何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 此外,誠如日期分別為二零二五年九月二十五日、二零二五年十月十六日及二零 二五年十一月六日之公告所披露: 於本公告日期,由於需要額外時間達 ...
国富量子(00290) - 股东特别大会(或其任何续会)之代表委任表格
2025-11-26 08:33
GoFintech Quantum Innovation Limited 國富量子創新有限公司 (前稱 GoFintech Innovation Limited 國富創新有限公司) (於開曼群島註冊成立之有限公司) (股份代號:290) 網址:https://290.com.hk 股東特別大會(或其任何續會)之 代表委任表格 本人╱吾等 (附註a) 地址為 為國富量子創新有限公司(「本公司」)股本中每股面值0.10港元普通股 股 (附註b) 之持有人,茲委任本公司股東特別大會(「大會」)主席,或委任 , 地址為 作為本人╱吾等之受委代表,代表本人╱吾等出席於二零二五年十二月十七日(星期三)上午十一時正假座香港皇后大道中183號 中遠大廈41樓4102-06室舉行之大會及其任何續會,並按照下列指示就召開之大會通告(「通告」)所載之決議案(「決議案」)投票, 如並無提供指示,則由本人╱吾等之受委代表酌情投票: | | | 普通決議案 | 贊成 (附註d) | 反對 (附註d) | | --- | --- | --- | --- | --- | | 1. | (a) | 批准貸款資本化協議及其項下擬進行之交易; | ...
国富量子(00290) - 股东特别大会通告
2025-11-26 08:33
香港交易及結算所有限公司及香港聯合交易所有限公司對本通告之內容概不負責, 對其準確性或完整性亦不發表任何聲明,並明確表示,概不對因本通告全部或任 何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 GoFintech Quantum Innovation Limited 國富量子創新有限公司 網址:https://290.com.hk (股份代號:290) 股東特別大會通告 茲通告國富量子創新有限公司(「本公司」)謹訂於二零二五年十二月十七日(星 期三)上午十一時正假座香港皇后大道中183號中遠大廈41樓4102-06室舉行股東特 別大會(「股東特別大會」),藉以考慮及酌情通過(不論有否修訂)下列決議案為 本公司普通決議案(除另有指明外,本通告所用詞彙與本公司日期為二零二五年 十一月二十六日之通函(「通函」)所界定者具有相同涵義): 普通決議案 1 1. 「動議: (a) 批准、確認及追認本公司與柳志偉博士(「貸款人」,作為認購人)訂立的 日期為二零二五年四月二十九日有關將本公司欠負認購人的金額約為 587,225,000港元的無抵押股東融資轉換為本公司股本(「貸款資本化」)之 貸款資本化協議(「 ...